Test Bank:
p
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo LatestE
p p p p p p p p p
dition, 2024
p
, Table of Contents
p p
Chapterp 1:p Anp Introductionp top Evidence-Basedp Clinicalp Practicep Guidelines .............................................. 3
Chapterp 2:p Pharmacokineticsp /Chapter3:p Pharmacodynamics .................................................................... 13
Chapter4:p Pharmacogeneticsp andp Pharmacogenomics ................................................................................ 25
Chapterp 5:p Pharmacologyp Acrossp thepLifepSpan ......................................................................................... 30
Chapterp 6:p Drug-Therapyp PrescribingpinpSpecialp Populations .................................................................... 36
Chapterp 7:p DrugpDevelopmentp andpApproval ............................................................................................. 45
Chapterp 8-Chapterp 10:pFoundationsp ofp Prescriptionp Writingp Chapterp 9:p ResponsibleControlled-
SubstancepPrescribingpChapterp 10:pAntibioticpStewardship ......................................................................... 51
Chapterp 11:p AppliedpCalculationsp forp Prescribing ...................................................................................... 58
Chapterp 12-:p Promotingp AdherencepWithpPharmacotherapyp II:p System-Specificp andpPatient-
FocusedpPrescribingpChapterp 13:p Pharmacotherapypforp Ear,p Nose,p Mouth,p andThroatp Conditionsp/Chapterp
14:pPharmacotherapypforp EyepConditions .................................................................................................... 67
Chapterp 15:p Pharmacotherapyp forp Skinp Conditions .................................................................................... 74
Chapterp 16:pPharmacotherapyp forp Neurologicp Conditions.......................................................................... 81
Chapterp 17:p Pharmacotherapyp forp Cardiovascularp Conditions ................................................................... 94
Chapterp 18:p Pharmacotherapyp forp Respiratoryp Conditions ....................................................................... 106
Chapterp 19:p Pharmacotherapyp forp Gastrointestinalp Conditionsp andp Conditionsp RequiringNutritionalpSupp
ort .............................................................................................................................................................. 117
Chapterp 20:pPharmacotherapyp forp Genitourinaryp Conditions ................................................................... 128
Chapterp 21:p Pharmacotherapypforp Renal,p Acid–Base,p Fluid,p andp ElectrolytepDisorders .......................... 133
Chapterp 22:p Pharmacotherapyp forp Musculoskeletalp andp Rheumatologicp Conditions ............................... 146
Chapterp 23:p Therapeuticp Applicationsp ofp Immunologyp andp Vaccines ..................................................... 158
Chapterp 24:pPharmacotherapyp forp Endocrinep Disorders ........................................................................... 163
Chapterp 25:pPharmacotherapyp forp Hematologicp Disorders ....................................................................... 174
Chapterp 26:p Hematology/Oncologyp andp Supportivep Carepforp thepNononcologist .................................... 190
Chapterp 27:pPharmacotherapyp Relatedp top Women’sp Healthp Conditions................................................... 196
Chapterp 28:p Pharmacotherapyp Relatedp top Men’sp Healthp Conditions ........................................................ 211
Chapterp 29:p Pharmacotherapyp Relatedp topTransgenderp Care .................................................................... 217
Chapterp 30:p Antimicrobialp Pharmacotherapy............................................................................................ 224
Chapterp 31:p Antiretroviralp Pharmacotherapy ............................................................................................ 235
Chapterp32:pPsychopharmacologypandpIntegrativepHealth:pCombinedpTreatmentpofPsychiatricpandpNeuroco
gnitivepConditions ..................................................................................................................................... 247
Chapterp 33:pPharmacotherapyp forp PainpManagement ............................................................................... 257
Chapterp 34:p Substancep UsepDisorderp III:p HealthpPromotionp andpMaintenance ........................................ 267
Chapterp 35:p Over-the-Counterp Medications .............................................................................................. 283
Chapterp 36:pPharmacotherapyp forp Obesity ................................................................................................ 291
,Chapterp1:pAnp Introductionp top Evidence-Basedp ClinicalpPracticep Guidelines
MULTIPLEpCHOICE
• Whatpispthepprimaryp purposep ofp thep nursingp assessment?
A. Identifyingp underlyingp pathologicp conditions
B. Assistingp thep physicianp inpidentifyingp medicalp conditions
C. Determiningp thep patientspmentalpstatus
D. Exploringp patientp responsesp top healthp problems
ANS:pD
Apnursingp assessmentp isp donep top identifypthep patientsp responsep tophealthppro
blems.pDuringp thep nursingp assessmentp phase,pap comprehensivepinformationp
basep isp developedp throughpap physicalpexamination,p nursingphistory,p medicati
onp history,p andpprofessionalp observation.p Identifyingpunderlyingp pathologicp
conditionsp andp assistingp thep physicianp inp identifyingpmedicalpconditionsp isp n
otppartpofpthep nursingpprocess.p Determiningp theppatientsp mentalpstatusp isp one
p partp ofp thep nursingp assessment,p butp itp isp notpthepprimaryppurpose.
DIF:p Cognitivep Level:p Comprehensionp
REF:pdmp 36pOBJ:p1p |p3pTOP:pNursingpP
rocesspStep:pAssessment
MSC:pNCLEXp Clientp Needsp Category:p Healthp Promotionp andp Maintenance
• Whatpispthep basisp ofpthep NANDApIp taxonomy?
A. Functionalp healthppatterns
B. Humanp responsep patterns
C. Basicp humanp needs
D. Pathophysiologicp needs
ANS:pB
ThepNANDApIptaxonomyp identifiesp humanp responsep patterns.pFunctiona
lpcomponentspofphealthppatternspareplimitedptopactivity,pfluidpvolume,pnutriti
on,pselfpcare,pandpsensorypperception.pBasicphumanpneedspcompriseplessptha
npmerelyphealthppatterns.p Pathophysiologicpneedsp arepnotppartpofpthepscop
epofpNANDApI.
, DIF:p Cognitivep Level:p Knowledgep
REF:ppp.p37-38pOBJ:p5pTOP:
Nursingp Processp Step:pDiagnosis
MSC:p NCLEXp Clientp Needsp Category:p Physiologicalp Integrity
• Whichptaskp ispincludedp inpthepassessmentp stepp ofpthep nursingp process?
A. Establishingp patientp goals/outcomes
B. Implementingp thep nursingp carep planp (NCP)
C. Measuringp goal/outcomep achievement
D. Collectingp andp communicatingp data
ANS:pD
Datap arep collectedp andp communicatedp inpthep assessmentp phasep ofp thepnursin
gpprocess.p Establishingp goalsp ispthep functionp ofp planning.
Implementingp thep NCPp isp thep functionp ofp implementation.p Measuringp
outcomepachievementp ispthepfunctionpofpevaluation.
DIF:p Cognitivep Level:p Comprehensionp
REF:pdmp 36pOBJ:p2p |p3pTOP:pNursingpP
rocesspStep:pAssessment
MSC:pNCLEXp Clientp Needsp Category:p Healthp Promotionp andp Maintenance
• Whichp statementp regardingp nursingp diagnosesp isp accurate?
a. Nursingp diagnosesp remainpthepsamep forpasp longpasp thepdiseasep isp present.
b. Nursingp diagnosesp arep writtenp top identifypdiseasepstates.
c. Nursingp diagnosesp describep patientp problemsp thatp nursesp treat.
d. Nursingp diagnosesp identifyp causesp relatedp top illness.
ANS:pC
Diagnosticp statementsp identifyp problemsp ap nursep isp independentlyp ablep toptr
eatp withinp thep scopep ofpprofessionalppractice.p Nursingp diagnosesp varypwithpt
hep changingp conditionp ofpthep patient.pThep responsep patternsp arepuniquep topth
eppatientp andparep notp diseasep specific.pNursingp diagnosespdescribeptheppatien
tsp humanpresponseppattern.
DIF:p Cognitivep Level:p Comprehension
p
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo LatestE
p p p p p p p p p
dition, 2024
p
, Table of Contents
p p
Chapterp 1:p Anp Introductionp top Evidence-Basedp Clinicalp Practicep Guidelines .............................................. 3
Chapterp 2:p Pharmacokineticsp /Chapter3:p Pharmacodynamics .................................................................... 13
Chapter4:p Pharmacogeneticsp andp Pharmacogenomics ................................................................................ 25
Chapterp 5:p Pharmacologyp Acrossp thepLifepSpan ......................................................................................... 30
Chapterp 6:p Drug-Therapyp PrescribingpinpSpecialp Populations .................................................................... 36
Chapterp 7:p DrugpDevelopmentp andpApproval ............................................................................................. 45
Chapterp 8-Chapterp 10:pFoundationsp ofp Prescriptionp Writingp Chapterp 9:p ResponsibleControlled-
SubstancepPrescribingpChapterp 10:pAntibioticpStewardship ......................................................................... 51
Chapterp 11:p AppliedpCalculationsp forp Prescribing ...................................................................................... 58
Chapterp 12-:p Promotingp AdherencepWithpPharmacotherapyp II:p System-Specificp andpPatient-
FocusedpPrescribingpChapterp 13:p Pharmacotherapypforp Ear,p Nose,p Mouth,p andThroatp Conditionsp/Chapterp
14:pPharmacotherapypforp EyepConditions .................................................................................................... 67
Chapterp 15:p Pharmacotherapyp forp Skinp Conditions .................................................................................... 74
Chapterp 16:pPharmacotherapyp forp Neurologicp Conditions.......................................................................... 81
Chapterp 17:p Pharmacotherapyp forp Cardiovascularp Conditions ................................................................... 94
Chapterp 18:p Pharmacotherapyp forp Respiratoryp Conditions ....................................................................... 106
Chapterp 19:p Pharmacotherapyp forp Gastrointestinalp Conditionsp andp Conditionsp RequiringNutritionalpSupp
ort .............................................................................................................................................................. 117
Chapterp 20:pPharmacotherapyp forp Genitourinaryp Conditions ................................................................... 128
Chapterp 21:p Pharmacotherapypforp Renal,p Acid–Base,p Fluid,p andp ElectrolytepDisorders .......................... 133
Chapterp 22:p Pharmacotherapyp forp Musculoskeletalp andp Rheumatologicp Conditions ............................... 146
Chapterp 23:p Therapeuticp Applicationsp ofp Immunologyp andp Vaccines ..................................................... 158
Chapterp 24:pPharmacotherapyp forp Endocrinep Disorders ........................................................................... 163
Chapterp 25:pPharmacotherapyp forp Hematologicp Disorders ....................................................................... 174
Chapterp 26:p Hematology/Oncologyp andp Supportivep Carepforp thepNononcologist .................................... 190
Chapterp 27:pPharmacotherapyp Relatedp top Women’sp Healthp Conditions................................................... 196
Chapterp 28:p Pharmacotherapyp Relatedp top Men’sp Healthp Conditions ........................................................ 211
Chapterp 29:p Pharmacotherapyp Relatedp topTransgenderp Care .................................................................... 217
Chapterp 30:p Antimicrobialp Pharmacotherapy............................................................................................ 224
Chapterp 31:p Antiretroviralp Pharmacotherapy ............................................................................................ 235
Chapterp32:pPsychopharmacologypandpIntegrativepHealth:pCombinedpTreatmentpofPsychiatricpandpNeuroco
gnitivepConditions ..................................................................................................................................... 247
Chapterp 33:pPharmacotherapyp forp PainpManagement ............................................................................... 257
Chapterp 34:p Substancep UsepDisorderp III:p HealthpPromotionp andpMaintenance ........................................ 267
Chapterp 35:p Over-the-Counterp Medications .............................................................................................. 283
Chapterp 36:pPharmacotherapyp forp Obesity ................................................................................................ 291
,Chapterp1:pAnp Introductionp top Evidence-Basedp ClinicalpPracticep Guidelines
MULTIPLEpCHOICE
• Whatpispthepprimaryp purposep ofp thep nursingp assessment?
A. Identifyingp underlyingp pathologicp conditions
B. Assistingp thep physicianp inpidentifyingp medicalp conditions
C. Determiningp thep patientspmentalpstatus
D. Exploringp patientp responsesp top healthp problems
ANS:pD
Apnursingp assessmentp isp donep top identifypthep patientsp responsep tophealthppro
blems.pDuringp thep nursingp assessmentp phase,pap comprehensivepinformationp
basep isp developedp throughpap physicalpexamination,p nursingphistory,p medicati
onp history,p andpprofessionalp observation.p Identifyingpunderlyingp pathologicp
conditionsp andp assistingp thep physicianp inp identifyingpmedicalpconditionsp isp n
otppartpofpthep nursingpprocess.p Determiningp theppatientsp mentalpstatusp isp one
p partp ofp thep nursingp assessment,p butp itp isp notpthepprimaryppurpose.
DIF:p Cognitivep Level:p Comprehensionp
REF:pdmp 36pOBJ:p1p |p3pTOP:pNursingpP
rocesspStep:pAssessment
MSC:pNCLEXp Clientp Needsp Category:p Healthp Promotionp andp Maintenance
• Whatpispthep basisp ofpthep NANDApIp taxonomy?
A. Functionalp healthppatterns
B. Humanp responsep patterns
C. Basicp humanp needs
D. Pathophysiologicp needs
ANS:pB
ThepNANDApIptaxonomyp identifiesp humanp responsep patterns.pFunctiona
lpcomponentspofphealthppatternspareplimitedptopactivity,pfluidpvolume,pnutriti
on,pselfpcare,pandpsensorypperception.pBasicphumanpneedspcompriseplessptha
npmerelyphealthppatterns.p Pathophysiologicpneedsp arepnotppartpofpthepscop
epofpNANDApI.
, DIF:p Cognitivep Level:p Knowledgep
REF:ppp.p37-38pOBJ:p5pTOP:
Nursingp Processp Step:pDiagnosis
MSC:p NCLEXp Clientp Needsp Category:p Physiologicalp Integrity
• Whichptaskp ispincludedp inpthepassessmentp stepp ofpthep nursingp process?
A. Establishingp patientp goals/outcomes
B. Implementingp thep nursingp carep planp (NCP)
C. Measuringp goal/outcomep achievement
D. Collectingp andp communicatingp data
ANS:pD
Datap arep collectedp andp communicatedp inpthep assessmentp phasep ofp thepnursin
gpprocess.p Establishingp goalsp ispthep functionp ofp planning.
Implementingp thep NCPp isp thep functionp ofp implementation.p Measuringp
outcomepachievementp ispthepfunctionpofpevaluation.
DIF:p Cognitivep Level:p Comprehensionp
REF:pdmp 36pOBJ:p2p |p3pTOP:pNursingpP
rocesspStep:pAssessment
MSC:pNCLEXp Clientp Needsp Category:p Healthp Promotionp andp Maintenance
• Whichp statementp regardingp nursingp diagnosesp isp accurate?
a. Nursingp diagnosesp remainpthepsamep forpasp longpasp thepdiseasep isp present.
b. Nursingp diagnosesp arep writtenp top identifypdiseasepstates.
c. Nursingp diagnosesp describep patientp problemsp thatp nursesp treat.
d. Nursingp diagnosesp identifyp causesp relatedp top illness.
ANS:pC
Diagnosticp statementsp identifyp problemsp ap nursep isp independentlyp ablep toptr
eatp withinp thep scopep ofpprofessionalppractice.p Nursingp diagnosesp varypwithpt
hep changingp conditionp ofpthep patient.pThep responsep patternsp arepuniquep topth
eppatientp andparep notp diseasep specific.pNursingp diagnosespdescribeptheppatien
tsp humanpresponseppattern.
DIF:p Cognitivep Level:p Comprehension
